- Joined
- Nov 25, 2015
- Messages
- 5,718
- Reaction score
- 2,605
https://www.usada.org/wp-content/uploads/wallet-card.pdf
CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION)
• Non-Approved Substances: pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use.
• Anabolic Agents:
androstenediol,
androstenedione,
androsterone,
bolandiol,
bolasterone,
boldenone,
clenbuterol,
danazol,
desoxymethyltestosterone (Madol),
dehydrochlormethyltestosterone (DHCMT),
Prasterone
(dehydroepiandrosterone, DHEA) and its metabolites,
drostanolone,
epitestosterone,
methasterone,
methyl-1-
testosterone,
methyltestosterone (Estratest, Covaryx),
nandrolone,
norboletone,
oxandrolone,
prostanozol,
selective androgen receptor modulators (SARMs, ostarine
(Enobosarm, MK-2866) andarine (GTx-007, S-4)),
stanozolol,
testosterone and its metabolites or isomers,
tetrahydrogestrinone (THG),
tibolone,
trenbolone,
zeranol,
zilpaterol, and similar substances.
• Beta-2 Agonists: All selective and non-selective
beta-2 agonists, including all optical isomers, are
prohibited. This includes all routes of administration
(e.g. oral, intravenous, and inhaled). Inhaled beta-2
agonists are prohibited, including
fenoterol,
higenamine
(Tinospora crispa),
indacaterol (Arcapta),
metaproternol
(Alupent),
orciprenaline,
olodaterol (Striverdi),
pirbuterol
(Maxair),
terbutaline (Brethaire),
vilanterol (Breo).
See other side for information on inhaled albuterol, formoterol, and salmeterol, which have uses that are not prohibited.
• Diuretics and Masking Agents: (see Diuretic
Warning on reverse side):
acetazolamide,
albumin,
amiloride,
bumetanide,
canrenone,
chlorthalidone,
chlorothiazide,
desmopressin (DDAVP),
dextran,
eplerenone,
furosemide,
glycerol,
glycerin,
hydrochlorothiazide/thiazides,
hydroxyethyl starch,
indapamide,
mannitol,
metolazone,
probenecid,
spironolactone,
tolvaptan,
conivaptan, & related
plasma expanders or diuretics;
Exceptions:
Drosperinone, local use of felypressin in a dental procedure, pamabrom, topical dorzolamide, and topical brinzolamide are not prohibited.
• Hormone and Metabolic Modulators:
Aromatase inhibitors:
aminoglutethimide (Cytadren),
anastrozole (Arimidex),
androstenetrione (6-oxo),
arimistane,
bicalutamide (Casodex),
exemestane(Aromasin),
formestane,
letrozole (Femara),
testolactone;
Selective Estrogen Receptor Modulators
(SERMS) and
Anti-Estrogens:
clomiphene,
cyclofenil,
fulvestrant,
ospemifene,
raloxifene,
tamoxifen,
toremifene;
Agents modifying myostatin functions;
Metabolic Modulators: activators of the AMP-activated
protein kinase (AICAR), and PPARδ agonists (GW
1516); insulin and insulin-mimetics; meldonium
(Mildronate); trimetazidine.
• Peptide Hormones, Growth Factors,Related Substances and Mimetics and all
releasing factors:
corticotropins (Cortrosyn, Acthar
HP),
Growth Hormone and its releasing factors and
analogues (hGH, GHRH, GH-Releasing Peptides,
Growth Hormone Sectretagogues, GHS)
CATEGORIES OF SUBSTANCES PROHIBITED AT ALL TIMES (IN AND OUT-OF-COMPETITION)
• Non-Approved Substances: pharmaceuticals with no approval by a governmental regulatory health authority for human therapeutic use.
• Anabolic Agents:
androstenediol,
androstenedione,
androsterone,
bolandiol,
bolasterone,
boldenone,
clenbuterol,
danazol,
desoxymethyltestosterone (Madol),
dehydrochlormethyltestosterone (DHCMT),
Prasterone
(dehydroepiandrosterone, DHEA) and its metabolites,
drostanolone,
epitestosterone,
methasterone,
methyl-1-
testosterone,
methyltestosterone (Estratest, Covaryx),
nandrolone,
norboletone,
oxandrolone,
prostanozol,
selective androgen receptor modulators (SARMs, ostarine
(Enobosarm, MK-2866) andarine (GTx-007, S-4)),
stanozolol,
testosterone and its metabolites or isomers,
tetrahydrogestrinone (THG),
tibolone,
trenbolone,
zeranol,
zilpaterol, and similar substances.
• Beta-2 Agonists: All selective and non-selective
beta-2 agonists, including all optical isomers, are
prohibited. This includes all routes of administration
(e.g. oral, intravenous, and inhaled). Inhaled beta-2
agonists are prohibited, including
fenoterol,
higenamine
(Tinospora crispa),
indacaterol (Arcapta),
metaproternol
(Alupent),
orciprenaline,
olodaterol (Striverdi),
pirbuterol
(Maxair),
terbutaline (Brethaire),
vilanterol (Breo).
See other side for information on inhaled albuterol, formoterol, and salmeterol, which have uses that are not prohibited.
• Diuretics and Masking Agents: (see Diuretic
Warning on reverse side):
acetazolamide,
albumin,
amiloride,
bumetanide,
canrenone,
chlorthalidone,
chlorothiazide,
desmopressin (DDAVP),
dextran,
eplerenone,
furosemide,
glycerol,
glycerin,
hydrochlorothiazide/thiazides,
hydroxyethyl starch,
indapamide,
mannitol,
metolazone,
probenecid,
spironolactone,
tolvaptan,
conivaptan, & related
plasma expanders or diuretics;
Exceptions:
Drosperinone, local use of felypressin in a dental procedure, pamabrom, topical dorzolamide, and topical brinzolamide are not prohibited.
• Hormone and Metabolic Modulators:
Aromatase inhibitors:
aminoglutethimide (Cytadren),
anastrozole (Arimidex),
androstenetrione (6-oxo),
arimistane,
bicalutamide (Casodex),
exemestane(Aromasin),
formestane,
letrozole (Femara),
testolactone;
Selective Estrogen Receptor Modulators
(SERMS) and
Anti-Estrogens:
clomiphene,
cyclofenil,
fulvestrant,
ospemifene,
raloxifene,
tamoxifen,
toremifene;
Agents modifying myostatin functions;
Metabolic Modulators: activators of the AMP-activated
protein kinase (AICAR), and PPARδ agonists (GW
1516); insulin and insulin-mimetics; meldonium
(Mildronate); trimetazidine.
• Peptide Hormones, Growth Factors,Related Substances and Mimetics and all
releasing factors:
corticotropins (Cortrosyn, Acthar
HP),
Growth Hormone and its releasing factors and
analogues (hGH, GHRH, GH-Releasing Peptides,
Growth Hormone Sectretagogues, GHS)
Last edited: